At the end of last year, RBV Capital participated in round B of the American biopharmaceutical startup Pipeline Therapeutics

This site uses cookies to make your browsing experience more convenient and personal. Cookies store useful information on your computer to help us improve the efficiency and relevance of our site for you. In some cases, they are essential to making the site work properly. By accessing this site, you consent to the use of cookies. Ok